Organ-like model for simulating tumors with different matrix rigidities in body

By adjusting the ratio of sodium alginate to matrix gel, tumor organoid models with different matrix stiffness were prepared, which solved the problem that the existing technology could not simulate the three-dimensional tumor growth environment in the body, and achieved in-depth research on tumor cell behavior and drug screening. New models are provided for clinical research.

CN119040267APending Publication Date: 2024-11-29FIRST AFFILIATED HOSPITAL OF DALIAN MEDICAL UNIV
View PDF 0 Cites 2 Cited by

Patent Information

Application Number
CN202411236966.5
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-05
Publication Date
2024-11-29

AI Technical Summary

Technical Problem

The existing tumor research models are mainly concentrated in planar cultured cell lines, and cannot effectively simulate the growth environment of three-dimensional tumor cells in vivo. In particular, the impact of matrix stiffness on tumor cell behavior and function has not been studied in depth.

Method used

Using a simulated tumor microenvironment composed of sodium alginate and matrix gel, an organoid model with different matrix stiffness was prepared by adjusting the ratio of sodium alginate to matrix gel, and different matrix environments in the body were simulated to study the biology of tumor cells. Characteristics and drug screening.

Benefits of technology

It provides a simple, highly repetitive three-dimensional tumor organoid model that can study the behavior of tumor cells and drug screening at different stroma stiffness, helps to understand the impact of stroma stiffness on tumor proliferation, adhesion and metastasis, and provides new clinical research in vitro model.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119040267A_ABST
    Figure CN119040267A_ABST
Patent Text Reader

Abstract

The invention belongs to the crossing field of cell engineering and biotechnology, and provides an organoid model for simulating tumors with different matrix rigidities in vivo, the model is composed of sodium alginate polysaccharide and matrigel in different proportions and organoid embedded in the sodium alginate polysaccharide and matrigel, and matrixes outside the organoid have different matrix rigidities; the preparation method has the greatest advantage that the tumor organs with different matrix rigidities can be prepared only by adjusting the concentration of the sodium alginate polysaccharide; the invention provides a reasonable, simple and easy-to-obtain organ-like model with high repeatability for fundamental research on tumors with different matrix rigidities clinically, screening of drugs for inhibiting tumor proliferation, adhesion and metastasis, research on drug resistance of tumor cells and the like.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the cross-field of cell engineering and biotechnology, and specifically is an organoid model for simulating tumors with different matrix stiffness in vivo. Background Art

[0002] The environment around the tumor provides cells with a variety of components that may be needed for survival and is the main factor affecting the behavior and function of tumor cells. Previous studies on tumors have mainly focused on regulating the various biochemical signals of cells. However, in recent years, studies have found that the mechanical properties of the extracellular matrix also play an extremely critical role in the development of tumors [SC Wei, J. Yang. Forcing through Tumor Metastasis: The interplay between tissue rigidity and epithelial-mesenchymal transition [J]. Trends in Cell Biology, 2016, 26 (2): 111-120]. In the study of mechanical properties, there have been many studies on the effect of extracellular matrix stiffness (simply put, the hardness of the extracellular environment) on the biological characteristics of tumor cells. For example, studies have shown that within a certain range, as the stiffness of the matrix increases, the spreading area and perimeter of liver cancer cells grow faster. When the stiffness continues to increase, the growth rate of the spreading area and perimeter decreases (T. Yeung, PC et al. Effects of substrate stiffness on cell morphology cytoskeletal structure and adhesion. Cell Motil Cytoskel, 2005, 60(1): 24-34.).

[0003] The biological characteristics of tumor cells are affected by the stiffness of the extracellular matrix. However, the models used in this conclusion are all flat cell lines, which cannot simulate the actual three-dimensional growth in vivo. In 2007, with the emergence of the first intestinal mucosal organoid, the study of cells rose to three-dimensional space. Organoids refer to tissue analogs with a certain spatial structure formed by three-dimensional (3D) culture in vitro using adult stem cells or pluripotent stem cells. Although organoids are not true human organs, they can simulate real organs in structure and function, can simulate the structure and function of in vivo tissues to the greatest extent, and can be cultured stably for a long time (hence they are also called "micro-organs"). Organoids have more advantages than traditional 2D culture and can show cell composition and behavior close to physiology. At present, the effect of matrix stiffness on organoids cultured in matrix gel needs further study. Summary of the invention

[0004] In order to solve the above technical problems, the present invention provides an organoid model that simulates tumors with different matrix stiffness in vivo to solve the problems raised in the background technology.

[0005] According to the first aspect of the present disclosure, an organoid model simulating tumors of different matrix stiffness in vivo is proposed, which is composed of matrix gel simulating the tumor microenvironment on the outside, sodium alginate and tumor organoids embedded on the inside, and includes the following preparation steps:

[0006] S1. Take sodium alginate with different G / M ratios and dissolve them in normal saline at a ratio of 0.5%-5.0%;

[0007] S2, mixing sodium alginate and matrigel evenly in a ratio of 5%-40%;

[0008] S3. Mix the above materials with organoid single cells and place them in a 37°C, CO2 incubator to allow the matrix gel to solidify for 10-40 minutes, then add Ca-containing 2+ The solidifying agent is added to fully combine the sodium alginate and the matrix gel and solidify, the solidifying agent is absorbed, and the organoid culture medium is added for culture;

[0009] S4. Change the medium every 2 to 3 days. The organoid culture time is 3-45 days.

[0010] Preferably, the sodium alginate is a natural polymer material and is composed of different concentrations. The mixture of sodium alginate and matrix gel provides a three-dimensional growth space for organoids, and the organoids and matrix materials have different degrees of adhesion and interaction.

[0011] Preferably, the number of organoids in the organoid model is 30-300, the diameter of the organoid model is 0.1-10 mm, and the hardness of the organoid model is 100 Pa-800 kPa.

[0012] Preferably, the organoids include pancreatic cancer organoids, bile duct cancer organoids, liver cancer organoids, colon cancer organoids, thyroid cancer organoids, breast cancer organoids, lung cancer organoids, kidney cancer organoids, stomach organoids, and normal tissue organoids of the above organs.

[0013] Preferably, the culture time of the organoid is 5-30 days.

[0014] According to the second aspect of the present disclosure, the application of hydrogel organoid spheres with adjustable hardness containing matrix gel in high-throughput drug screening is also proposed.

[0015] Compared with the prior art, the present invention has the following beneficial effects:

[0016] 1. The model of the present invention is composed of different proportions of sodium alginate polysaccharide and matrix gel and organoids embedded therein, and the matrix outside the organoids has different matrix stiffness.

[0017] 2. The greatest advantage of the present invention is that tumor organoids with different matrix stiffness can be prepared simply by adjusting the concentration of sodium alginate polysaccharide. This provides a reasonable, simple, and highly reproducible organoid model for basic research on tumors with different matrix stiffness, screening of drugs that inhibit tumor proliferation, adhesion, and metastasis, and research on drug resistance of tumor cells.

[0018] 3. The cells focused on in the present invention are three-dimensionally cultured tumor organoids. The biological effects of matrix stiffness on organoids are explored at the three-dimensional structural level. Three-dimensional models with different matrix stiffness can be prepared simply by adjusting the ratio of matrix gel to sodium alginate. This provides organoid models with different matrix stiffness for basic research and provides a new in vitro model for drug screening of tumor cells with different matrix stiffness in clinical trials. BRIEF DESCRIPTION OF THE DRAWINGS

[0019] Figure 1 A flow chart for preparing an organoid model for simulating tumors with different matrix stiffness in vivo according to the present invention;

[0020] Figure 2 This is a characterization diagram of the Young's modulus of organoids with different matrix stiffness prepared with different sodium alginate addition amounts of the present invention;

[0021] Figure 3 This is a diagram showing the expression of pancreatic cancer metastasis-related genes in organoids under different matrix stiffness culture conditions of the present invention; wherein a is the mos gene, b is the myc gene, c is the raf gene, d is the erbB2 gene, e is the fes gene, f is the fms gene, and g is the ras gene;

[0022] Figure 4 This is a characterization diagram of the compression modulus of organoids with different matrix stiffnesses of the present invention. DETAILED DESCRIPTION

[0023] The following embodiments of the present invention are described in further detail in conjunction with the accompanying drawings and examples. The following examples are used to illustrate the present invention, but are not intended to limit the scope of the present invention.

[0024] As attached Figure 1 To Attachment Figure 4 As shown:

[0025] Embodiment 1: The present invention provides an organoid model simulating tumors of different matrix stiffness in vivo, which is composed of matrix gel simulating the tumor microenvironment on the outside, sodium alginate and tumor organoids embedded on the inside, and includes the following preparation steps:

[0026] S1. Take sodium alginate with different G / M ratios and dissolve them in normal saline at a ratio of 0.5%-5.0%;

[0027] S2, mixing sodium alginate and matrigel evenly in a ratio of 5%-40%;

[0028] S3. Mix the above materials with organoid single cells and place them in a 37°C, CO2 incubator to allow the matrix gel to solidify for 10-40 minutes, then add Ca-containing 2+ The solidifying agent is added to fully combine the sodium alginate and the matrix gel and solidify, the solidifying agent is absorbed, and the organoid culture medium is added for culture;

[0029] S4. Change the medium every 2 to 3 days. The organoid culture time is 5-30 days.

[0030] Sodium alginate is a natural polymer material, composed of different concentrations. The mixture of sodium alginate and matrix gel provides a three-dimensional growth space for organoids, and the organoids and matrix materials have different degrees of adhesion and interaction.

[0031] The number of organoids in the organoid model is 30-300, the diameter of the organoid model is 0.1-10 mm, and the hardness of the organoid model is 100 Pa-800 kPa.

[0032] Organoids include pancreatic cancer organoids, bile duct cancer organoids, liver cancer organoids, colon cancer organoids, thyroid cancer organoids, breast cancer organoids, lung cancer organoids, kidney cancer organoids, stomach organoids, and normal tissue organoids of the above organs.

[0033] The application of hydrogel organoid spheres with adjustable hardness containing matrix gel in high-throughput drug screening is also proposed.

[0034] Embodiment 2: Figure 2 As shown, pancreatic cancer organoids were prepared by adjusting the concentration of sodium alginate to obtain organoids with three different matrix stiffnesses;

[0035] The above organoids were used to investigate the expression of tumor metastasis-related genes in pancreatic cancer organoids with different matrix stiffness, such as Figure 3 As shown in the figure, some genes closely related to pancreatic cancer metastasis are mostly highly expressed in organoids with high matrix stiffness. Therefore, this model can be used to screen drugs for the treatment of pancreatic cancer metastasis.

[0036] Example 3: Pancreatic cancer organoids Organoids with three different matrix stiffnesses were prepared by adjusting the concentration of sodium alginate. The stiffness of the matrix in which the organoids were embedded was tested using a universal mechanics tester, and the data were quantitatively analyzed.

[0037] like Figure 4As shown in the figure, the matrix stiffness of pure matrigel is low, only about 10 N. With the addition of sodium alginate gel, the matrix stiffness of the sodium alginate-matrigel mixed gel system gradually increases, which is manifested in that the pressure required for the gel block to undergo the same deformation is greater. This proves that the system can be used to simulate tumor microenvironments with different hardness in vivo.

[0038] Importantly, it should be noted that the construction and arrangement of the present application shown in a plurality of different exemplary embodiments are only exemplary. Although only a few embodiments are described in detail in this disclosure, it should be readily understood by those who refer to this disclosure that many modifications are possible (e.g., the size, scale, structure, shape and proportion of various elements, as well as parameter values ​​(e.g., temperature, pressure, etc.), mounting arrangements, use of materials, color, directional changes, etc.) without substantially departing from the novel teachings and advantages of the subject matter described in the application. For example, the element shown as integrally formed can be composed of multiple parts or elements, the position of the element can be inverted or otherwise changed, and the nature or number or position of the discrete element can be changed or changed. Therefore, all such modifications are intended to be included in the scope of the present invention. The order or sequence of any process or method steps can be changed or reordered according to alternative embodiments. In the claims, any "device plus function" clause is intended to cover the structure described herein that performs the function, and is not only structurally equivalent but also equivalent structure. Without departing from the scope of the present invention, other replacements, modifications, changes and omissions can be made in the design, operating conditions and arrangement of the exemplary embodiments. Therefore, the invention is not limited to a specific embodiment, but extends to several modifications still falling within the scope of the appended claims.

[0039] Additionally, in order to provide a concise description of exemplary embodiments, all features of an actual embodiment (ie, those features that are not relevant to the best mode presently contemplated for carrying out the invention or those that are not relevant to implementing the invention) may not be described.

[0040] It will be appreciated that in the development of any actual implementation, as in any engineering or design project, numerous implementation-specific decisions may be made. Such a development effort may be complex and time-consuming, but will be a routine task of design, fabrication, and production for those of ordinary skill having the benefit of this disclosure without undue experimentation.

[0041] It should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention rather than to limit it. Although the present invention has been described in detail with reference to the preferred embodiments, those skilled in the art should understand that the technical solutions of the present invention may be modified or replaced by equivalents without departing from the spirit and scope of the technical solutions of the present invention, which should all be included in the scope of the claims of the present invention.

Claims

1. An organoid model that simulates tumors of different matrix stiffness in vivo, characterized by: The system is composed of matrix gel and sodium alginate that simulate the tumor microenvironment on the outside and tumor organoids embedded inside, and includes the following preparation steps: S1. Take sodium alginate with different G / M ratios and dissolve them in normal saline at a ratio of 0.5%-5.0%; S2, mixing sodium alginate and matrigel evenly in a ratio of 5%-40%; S3. Mix the above materials with organoid single cells and place them in a 37°C, CO2 incubator to allow the matrix gel to solidify for 10-40 minutes, then add Ca-containing 2+ The solidifying agent is added to fully combine the sodium alginate and the matrix gel and solidify, the solidifying agent is absorbed, and the organoid culture medium is added for culture; S4. Change the medium every 2 to 3 days. The organoid culture time is 5-45 days.

2. An organoid model for simulating tumors with different matrix stiffness in vivo according to claim 1, characterized in that: The sodium alginate is a natural polymer material and is composed of different concentrations. The mixture of sodium alginate and matrix gel provides a three-dimensional growth space for organoids, and the organoids and the matrix material have different degrees of adhesion and interaction.

3. The organoid model for simulating tumors with different matrix stiffness in vivo according to claim 1, characterized in that: The number of organoids in the organoid model is 30-300, the diameter of the organoid model is 0.1-10 mm, and the hardness of the organoid model is 100 Pa-800 kPa.

4. The organoid model for simulating tumors with different matrix stiffness in vivo according to claim 1, characterized in that: The organoids include pancreatic cancer organoids, bile duct cancer organoids, liver cancer organoids, colon cancer organoids, thyroid cancer organoids, breast cancer organoids, lung cancer organoids, kidney cancer organoids, stomach organoids, and normal tissue organoids of the above organs.

5. The organoid model for simulating tumors with different matrix stiffness in vivo according to claim 1, characterized in that: The culture time of the organoid is 5-30 days.

6. An organoid model for simulating tumors with different matrix stiffness in vivo according to any one of claims 1 to 5, characterized in that: Matrigel-containing hydrogel organoid spheroids with adjustable stiffness for high-throughput drug screening.

Citation Information

Cited By

  • Bionic hydrogel for culturing tongue cancer organoid and application

    CN120795425A

  • Organ-like culture method for simulating hardness of tumor tissue of patient and application

    CN121737036A